CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Jan. 01, 2016		Jan. 02, 2015
Cash flows from operating activities:
Net earnings	$ 89,042		$ 93,314
Adjustments to reconcile net earnings to net cash provided by operating activities:
Share-based compensation expense	11,255		12,737
Tax benefits from exercises of share-based payment awards	1,044		6,264
Excess tax benefits from share-based compensation	(1,101)		(6,239)
Depreciation	15,483		15,424
Amortization of intangible assets	2,987		1,647
Deferred taxes	(3,223)		14,110
Provision for doubtful accounts receivable	3,997		7,901
Other, net	1,051		217
Changes in assets and liabilities:
Accounts receivable	(29,461)		43,720
Inventories	(3,989)		(62,149)
Prepaid expenses and other assets	(11,956)		(8,035)
Accounts payable	(14,177)		(37,012)
Accrued liabilities and other long-term liabilities	5,288		(25,572)
Deferred revenues and advance payments from customers	10,982		22,625
Net cash provided by operating activities	77,222		78,952
Cash flows from investing activities:
Purchases of property, plant and equipment	(27,308)		(21,723)
Investment in available-for-sale securities	(880)		(942)
Sale of available-for-sale securities	8,638		0
Notes receivable	(2,069)		(3,000)
Amounts paid to deferred compensation plan trust account	(2,725)		0
Other	84		87
Net cash used in investing activities	(24,260)		(25,578)
Cash flows from financing activities:
Repurchases of common stock	(192,077)		(125,535)
Proceeds from issuance of common stock to employees	15,329		34,795
Excess tax benefits from share-based compensation	1,101		6,239
Employees' taxes withheld and paid for restricted stock and restricted stock units	(4,477)		(11,362)
Borrowings under credit facility agreement	75,000		0
Repayments under credit facility agreement	(67,500)		(12,500)
Net borrowings under credit facility agreements with maturities less than 90 days	225,000		100,000
Contingent consideration and hold back	(2,550)		(734)
Other	0		1,774
Net cash provided by (used in) financing activities	49,826		(7,323)
Effects of exchange rate changes on cash and cash equivalents	5,121		9,033
Net increase in cash and cash equivalents	107,909		55,084
Cash and cash equivalents at beginning of period	845,468	[1]	849,275
Cash and cash equivalents at end of period	$ 953,377		$ 904,359

[1] The condensed consolidated balance sheet as of October 2, 2015 was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.